Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
The US FDA is currently reviewing its pharmaceutical manufacturing Guidance, after receiving feedback from industry trade groups. What will the new Guidance mean for pharma companies, as well as ...
GlobalData on MSN8d
FDA protocol deviation guidance could go furtherThe US Food and Drug Administration has released draft guidance on protocol deviations, but experts say it could go further.
The bill's supporters framed it as part of the solution to addressing both high drug prices and slowing the pace of pharmacy ...
In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...
Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...
Drug manufacturers must thoroughly ... in the interpretation and application of technical guidelines and requirements for the pharmaceutical industry. The growth promotion test The Growth ...
China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback